{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "AI based screening",
      "Drug designing",
      "Drug repurposing",
      "E protein",
      "Molecular docking simulations",
      "Nutraceuticals",
      "Pattern recognition",
      "SARS-CoV-2 infection"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33189776",
  "DateCompleted": {
    "Year": "2021",
    "Month": "02",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "11",
        "Day": "13"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.ygeno.2020.11.009",
      "S0888-7543(20)32007-3"
    ],
    "Journal": {
      "ISSN": "1089-8646",
      "JournalIssue": {
        "Volume": "113",
        "Issue": "1 Pt 2",
        "PubDate": {
          "Year": "2021",
          "Month": "Jan"
        }
      },
      "Title": "Genomics",
      "ISOAbbreviation": "Genomics"
    },
    "ArticleTitle": "Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.",
    "Pagination": {
      "StartPage": "1129",
      "EndPage": "1140",
      "MedlinePgn": "1129-1140"
    },
    "Abstract": {
      "AbstractText": [
        "COVID-19 pandemic caused by SARS-CoV-2 has already claimed millions of lives worldwide due to the absence of a suitable anti-viral therapy. The CoV envelope (E) protein, which has not received much attention so far, is a 75 amino acid long integral membrane protein involved in assembly and release of the virus inside the host. Here we have used artificial intelligence (AI) and pattern recognition techniques for initial screening of FDA approved pharmaceuticals and nutraceuticals to target this E protein. Subsequently, molecular docking simulations have been performed between the ligands and target protein to screen a set of 9 ligand molecules. Finally, we have provided detailed insight into their mechanisms of action related to the varied symptoms of infected patients."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020. Published by Elsevier Inc."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Bioinformatics, Bose Institute, P-1/12, CIT Scheme VIIM, Kankurgachi, Kolkata 700 054, India. Electronic address: gourab4gd@gmail.com."
          }
        ],
        "LastName": "Das",
        "ForeName": "Gourab",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Bioinformatics, Bose Institute, P-1/12, CIT Scheme VIIM, Kankurgachi, Kolkata 700 054, India. Electronic address: troyee@jcbose.ac.in."
          }
        ],
        "LastName": "Das",
        "ForeName": "Troyee",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, Nadia 741235, West Bengal, India. Electronic address: nil5two@gmail.com."
          }
        ],
        "LastName": "Chowdhury",
        "ForeName": "Nilkanta",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Bioinformatics, Bose Institute, P-1/12, CIT Scheme VIIM, Kankurgachi, Kolkata 700 054, India. Electronic address: cdurbadal@gmail.com."
          }
        ],
        "LastName": "Chatterjee",
        "ForeName": "Durbadal",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biochemistry and Biophysics, University of Kalyani, Kalyani, Nadia 741235, West Bengal, India. Electronic address: angshu@klyuniv.ac.in."
          }
        ],
        "LastName": "Bagchi",
        "ForeName": "Angshuman",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Bioinformatics, Bose Institute, P-1/12, CIT Scheme VIIM, Kankurgachi, Kolkata 700 054, India. Electronic address: zhumur@jcbose.ac.in."
          }
        ],
        "LastName": "Ghosh",
        "ForeName": "Zhumur",
        "Initials": "Z"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Genomics",
    "NlmUniqueID": "8800135",
    "ISSNLinking": "0888-7543"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Coronavirus Envelope Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "envelope protein, SARS-CoV-2"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Artificial Intelligence"
    },
    {
      "QualifierName": [
        "diet therapy",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Conserved Sequence"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics"
      ],
      "DescriptorName": "Coronavirus Envelope Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dietary Supplements"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Drug Evaluation, Preclinical"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Repositioning"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Machine Learning"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Molecular"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Docking Simulation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pattern Recognition, Automated"
    },
    {
      "QualifierName": [
        "chemistry",
        "drug effects",
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "User-Computer Interface"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}